474 related articles for article (PubMed ID: 28495918)
1. Bone marrow morphology is a strong discriminator between chronic eosinophilic leukemia, not otherwise specified and reactive idiopathic hypereosinophilic syndrome.
Wang SA; Hasserjian RP; Tam W; Tsai AG; Geyer JT; George TI; Foucar K; Rogers HJ; Hsi ED; Rea BA; Bagg A; Bueso-Ramos CE; Arber DA; Verstovsek S; Orazi A
Haematologica; 2017 Aug; 102(8):1352-1360. PubMed ID: 28495918
[TBL] [Abstract][Full Text] [Related]
2. Targeted next-generation sequencing identifies a subset of idiopathic hypereosinophilic syndrome with features similar to chronic eosinophilic leukemia, not otherwise specified.
Wang SA; Tam W; Tsai AG; Arber DA; Hasserjian RP; Geyer JT; George TI; Czuchlewski DR; Foucar K; Rogers HJ; Hsi ED; Bryan Rea B; Bagg A; Dal Cin P; Zhao C; Kelley TW; Verstovsek S; Bueso-Ramos C; Orazi A
Mod Pathol; 2016 Aug; 29(8):854-64. PubMed ID: 27174585
[TBL] [Abstract][Full Text] [Related]
3. Eosinophilia/Hypereosinophilia in the Setting of Reactive and Idiopathic Causes, Well-Defined Myeloid or Lymphoid Leukemias, or Germline Disorders.
Kelemen K; Saft L; Craig FE; Orazi A; Nakashima M; Wertheim GB; George TI; Horny HP; King RL; Quintanilla-Martinez L; Wang SA; Rimsza LM; Reichard KK
Am J Clin Pathol; 2021 Feb; 155(2):179-210. PubMed ID: 33367563
[TBL] [Abstract][Full Text] [Related]
4. The Diagnostic Work-Up of Hypereosinophilia.
Wang SA
Pathobiology; 2019; 86(1):39-52. PubMed ID: 29961056
[TBL] [Abstract][Full Text] [Related]
5. Hypereosinophilic syndrome and clonal eosinophilia: point-of-care diagnostic algorithm and treatment update.
Tefferi A; Gotlib J; Pardanani A
Mayo Clin Proc; 2010 Feb; 85(2):158-64. PubMed ID: 20053713
[TBL] [Abstract][Full Text] [Related]
6. Chronic eosinophilic leukemia with recurrent STAT5B N642H mutation-An entity with features of myelodysplastic syndrome/ myeloproliferative neoplasm overlap.
Sreedharanunni S; Jamwal M; Balakrishnan A; Aravindan AV; Sharma R; Singh N; Rajpal S; Singla S; Khadwal AR; Ahluwalia J; Malhotra P; Das R
Leuk Res; 2022 Jan; 112():106753. PubMed ID: 34856508
[No Abstract] [Full Text] [Related]
7. Clonal eosinophilic disorders and the hypereosinophilic syndrome.
Brito-Babapulle F
Blood Rev; 1997 Sep; 11(3):129-45. PubMed ID: 9370044
[TBL] [Abstract][Full Text] [Related]
8. Atypical myeloproliferative disorders: diagnosis and management.
Tefferi A; Elliott MA; Pardanani A
Mayo Clin Proc; 2006 Apr; 81(4):553-63. PubMed ID: 16610578
[TBL] [Abstract][Full Text] [Related]
9. Diagnosing myelodysplastic/myeloproliferative neoplasms: laboratory testing strategies to exclude other disorders.
Hall J; Foucar K
Int J Lab Hematol; 2010 Dec; 32(6 Pt 2):559-71. PubMed ID: 20670271
[TBL] [Abstract][Full Text] [Related]
10. Histopathology in the diagnosis and classification of acute myeloid leukemia, myelodysplastic syndromes, and myelodysplastic/myeloproliferative diseases.
Orazi A
Pathobiology; 2007; 74(2):97-114. PubMed ID: 17587881
[TBL] [Abstract][Full Text] [Related]
11. Updates on eosinophilic disorders.
Tzankov A; Reichard KK; Hasserjian RP; Arber DA; Orazi A; Wang SA
Virchows Arch; 2023 Jan; 482(1):85-97. PubMed ID: 36068374
[TBL] [Abstract][Full Text] [Related]
12. World Health Organization-defined eosinophilic disorders: 2014 update on diagnosis, risk stratification, and management.
Gotlib J
Am J Hematol; 2014 Mar; 89(3):325-37. PubMed ID: 24577808
[TBL] [Abstract][Full Text] [Related]
13. Physician Education: Myelodysplastic Syndrome.
Yoshida Y
Oncologist; 1996; 1(4):284-287. PubMed ID: 10388004
[TBL] [Abstract][Full Text] [Related]
14. [Idiopathic and symptomatic hypereosinophilic syndromes (their comparative characteristics based on 14 cases)].
Khoroshko ND; Mokeeva RA; Turkina AG; Semenova EA; Pivnik AV
Ter Arkh; 1997; 69(7):26-33. PubMed ID: 9424754
[TBL] [Abstract][Full Text] [Related]
15. Myeloid/lymphoid neoplasms with eosinophilia and FLT3 rearrangement.
Shao H; Wang W; Song J; Tang G; Zhang X; Tang Z; Srivastava J; Shah B; Medeiros LJ; Zhang L
Leuk Res; 2020 Dec; 99():106460. PubMed ID: 33166908
[TBL] [Abstract][Full Text] [Related]
16. The eosinophilias, including the idiopathic hypereosinophilic syndrome.
Brito-Babapulle F
Br J Haematol; 2003 Apr; 121(2):203-23. PubMed ID: 12694242
[No Abstract] [Full Text] [Related]
17. A Test Utilization Approach to the Diagnostic Workup of Isolated Eosinophilia in Otherwise Morphologically Unremarkable Bone Marrow: A Single Institutional Experience.
Fang H; Ketterling RP; Hanson CA; Pardanani A; Kurtin PJ; Chen D; Greipp PT; Howard MT; King RL; Van Dyke DL; Reichard KK
Am J Clin Pathol; 2018 Oct; 150(5):421-431. PubMed ID: 30032299
[TBL] [Abstract][Full Text] [Related]
18. [Chromosomic characteristics associated with leukemia and other hemopathies in Costa Rica].
Castro Volio I; Montero Umaña C; Jiménez Cruz G
Rev Biol Trop; 1993 Dec; 41(3A):385-92. PubMed ID: 7701079
[TBL] [Abstract][Full Text] [Related]
19. A multimodality work-up of patients with Hypereosinophilia.
Hu Z; Boddu PC; Loghavi S; Miranda RN; Goswami M; Medeiros LJ; Tam W; Orazi A; Verstovsek S; Wang SA
Am J Hematol; 2018 Nov; 93(11):1337-1346. PubMed ID: 30105844
[TBL] [Abstract][Full Text] [Related]
20. Chronic myeloid leukemia associated hypereosinophilic syndrome with a clonal t(4;7)(q11;q32).
Duell T; Mittermüller J; Schmetzer HM; Kolb HJ; Wilmanns W
Cancer Genet Cytogenet; 1997 Apr; 94(2):91-4. PubMed ID: 9109934
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]